Kristin DePeaux

6PUBLICATIONS
19CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 08, 2023
An oncolytic virus-delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment.

Kristin DePeaux, Dayana B Rivadeneira, Konstantinos Lontos

|Dec 21, 2022
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity.

Paolo D A Vignali, Kristin DePeaux, McLane J Watson

|Apr 30, 2021
Metabolic barriers to cancer immunotherapy.

Kristin DePeaux, Greg M Delgoffe

|Feb 16, 2021
Metabolic support of tumour-infiltrating regulatory T cells by lactic acid.

McLane J Watson, Paolo D A Vignali, Steven J Mullett

|Jan 05, 2021
Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion.

Nicole E Scharping, Dayana B Rivadeneira, Ashley V Menk

|Jul 24, 2019
The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity.

Sangeetha Palakurthi, Mari Kuraguchi, Sima J Zacharek

Pageof 1